<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title> LGT Obstetric Anaesthesia – Quick Reference</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<style>
body {
  font-family: system-ui, -apple-system, BlinkMacSystemFont, sans-serif;
  margin: 0;
  padding: 0;
  background: #f7f7f7;
  color: #222;
}

header {
  background: #003366;
  color: white;
  padding: 1rem;
  text-align: center;
}

.container {
  padding: 1rem;
  max-width: 900px;
  margin: auto;
}

details {
  background: white;
  border-radius: 6px;
  margin-bottom: 0.75rem;
  padding: 0.75rem 1rem;
  box-shadow: 0 2px 5px rgba(0,0,0,0.05);
}

summary {
  font-weight: 600;
  font-size: 1.05rem;
  cursor: pointer;
}

ul {
  margin-top: 0.5rem;
}

.section-title {
  margin-top: 1.5rem;
  font-weight: 700;
  font-size: 1.2rem;
}

.footer {
  font-size: 0.8rem;
  text-align: center;
  padding: 1rem;
  color: #666;
}
</style>
</head>

<body>

<header>
  <h1>LGT Obstetric Anaesthesia</h1>
  <p>Quick Reference Guide</p>
</header>

<div class="container">

<div class="section-title">LSCS – Regional Anaesthesia</div>

<details>
<summary>Spinal – Standard</summary>
<ul>
<li>14–16G IV access, warmed fluids running</li>
<li>2.2–2.5 ml 0.5% heavy bupivacaine + 300 mcg diamorphine</li>
<li>Phenylephrine infusion 50mcg/ml started at 40ml/hr</li>
<li>Aiming bilateral sensory block T4-S3</li>
</ul>
</details>

<details>
<summary>CSE</summary>
<ul>
<li>Consider for prolonged surgery or patients with complex medical conditions </li>
<li>Reduce spinal dose in cardiac disease, short stature, obesity</li>
<li>Phenylephrine as above</li>
<li>Tegaderm dressing + mefix strip</li>
</ul>
</details>

<details>
<summary>Epidural Top-Up</summary>
<ul>
<li>Only if functioning adequately. If not, remove and place spinal</li>
<li>0.5% bupivacaine or 0.75% ropivacaine 15–20 ml in 5 ml increments</li>
<li>OR 2% lidocaine + adrenaline 1:200,000 (0.1ml 1:1000 adrenaline in 20ml 2% lidocaine)</li>
<li>Add fentanyl 50–100 mcg</li>
<li>Diamorphine 3 mg (or preservative-free morphine 3mg) down epidural at end for post-op analgesia</li>
<li>Remove epidural unless contraindicated (e.g. coagulopathy) or high risk of return to theatre</li>
</ul>
</details>

<div class="section-title">LSCS – General Anaesthesia</div>

<details>
<summary>Key Points</summary>
<ul>
<li>Category 1 emergencies / neuraxial contraindicated</li>
<li>Ranitidine 150 mg PO or 50 mg IV</li>
<li>Sodium citrate 30 ml PO</li>
<li>Pre-oxygenate (HFNO if available)</li>
<li>RSI with cricoid pressure</li>
<li>Propofol or thiopentone</li>
<li>Suxamethonium or rocuronium</li>
<li>Consider VL, size 7 COETT</li>
</ul>
</details>

<div class="section-title">LSCS - Post-op care</div>

<details>
<summary>End of Surgery</summary>
<ul>
<li>Paracetamol 1 g IV/PR</li>
<li>Diclofenac 100 mg PR</li>
</ul>
</details>

<details>
<summary>Post-Op Prescription - 'C-section Medication Inpatient Protocol)</summary>
<ul>
<li>Paracetamol 1 g QDS</li>
<li>Ibuprofen 400 mg TDS–QDS</li>
<li>Morphine Sulphate MR 10mg BD for 2 doses</li>
<li>Morphine Sulphate IR 10–20 mg 2-hourly PRN</li>
<li>Cyclizine 50mg PO TDS</li>
<li>Ondansetron 4mg IV TDS</li>
<li>Chlorphenamine 4mg PO QDS</li>
<li>Naloxone 25mcg SC hourly (max 3 doses)</li>
</ul>
</details>

<div class="section-title">6. Labour Analgesia</div>

<details>
<summary>Epidural</summary>
<ul>
<li>L2/3 – L4/5, 16G Tuohy</li>
<li>Catheter 4–5 cm in space</li>
<li>Test dose: 0.1% bupivacaine + fentanyl</li>
<li>PCEA or infusion as per policy</li>
</ul>
</details>

<details>
<summary>Remifentanil PCA</summary>
<ul>
<li>Only with uninterrupted 1:1 midwifery care</li>
<li>Dedicated IV access</li>
<li>RR and SpO₂ every 15 minutes</li>
</ul>
</details>

<div class="section-title">7. Post-Partum Haemorrhage</div>

<details>
<summary>Initial Management</summary>
<ul>
<li>High-flow O₂</li>
<li>2 large-bore IV lines</li>
<li>Warm fluids</li>
<li>Activate MHP if &gt;1.5 L</li>
<li>TXA 1 g IV</li>
</ul>
</details>

<details>
<summary>Uterotonics</summary>
<ul>
<li>Syntocinon 5 IU IV + infusion</li>
<li>Ergometrine 500 mcg IM (avoid PET)</li>
<li>Carboprost 250 mcg IM (avoid asthma)</li>
<li>Misoprostol 0.4–1 mg PR</li>
</ul>
</details>

</div>

<div class="footer">
Based on EAOAG Obstetric Anaesthesia Quick Reference Guide (2018)
</div>

</body>
</html>
